TNF and metabolic disease: Circulating TNF‐α levels are elevated in individuals with obesity and T2DM and correlate positively with measures of insulin resistance, such as the homeostasis model assessment of insulin resistance (HOMA‐IR), further implicating TNF‐α–driven inflammation in the pathogenesis of metabolic disease (19).